-
-
-
-
-
-
-
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
-
-
-
-
-
-
-
Orchard Therapeutics (ORTX) Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT
-
-
-
-
-
-
-
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
-
-
-
-
-
-
-
Oxford Biomedica announces strategic investment by Serum Life Sciences Ltd
-
-
-
-
-
-
-
Cryoport Reports Record Results for Full Year 2020
-
-
-
-
-
-
-
Orchard Therapeutics Plc (ORTX) Highlights Additional Interim Results from Proof-of-Concept Study of OTL-203 for MPS-I
-
-
-
-
-
-
-
Orchard Therapeutics Plc (ORTX) Announces Steven Altschuler, M.D. to Board
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

